Spatially resolved transcriptomic profiling identifies distinct signatures in parenchymal and vascular microenvironments in Alzheimer's Disease with Cerebral Amyloid Angiopathy
Alzheimer's & Dementia · 2026-02 · 22 (2)
DOI: 10.1002/alz.71208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 22.02.2026. Verfasst von Enrique Chimal-Juárez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Alzheimer Disease, Brain, Parenchymal Tissue. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Rainwater Charitable Foundation, Cure Alzheimer's Fund.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Alzheimer's disease (AD) pathology frequently coexists with cerebral amyloid angiopathy (CAA), in which amyloid beta (Aβ) deposits in cerebral blood vessels. Although anti‐Aβ immunotherapies can reduce parenchymal plaques, they often exacerbate vascular pathology. This study investigates compartment‐specific microenvironmental responses to parenchymal versus vascular amyloid deposition. METHODS We performed spatial whole‐transcriptomic profiling on postmortem brain tissue from individuals with mixed AD/CAA pathology. Gene expression signatures were compared between parenchymal and vascular compartments to identify microenvironment‐specific responses to amyloid deposition. RESULTS Analysis revealed that the vascular amyloid microenvironment is distinct from that of parenchymal amyloid, particularly in how shared pathways are differentially upregulated. Notably, although elements of the matrisome were activated in both contexts, they exhibited distinct expression patterns depending on the microenvironment. DISCUSSION These findings highlight the dynamic and context‐dependent nature of the microenvironment in AD/CAA. Our results emphasize the need for compartment‐specific therapeutic strategies to mitigate amyloid pathology and reduce treatment‐related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Division of Neuropathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Cristian A Lasagna-Reeves
Förderung
- NIA NIH HHS
- Rainwater Charitable Foundation
- Cure Alzheimer's Fund
- NINDS NIH HHS
- Alzheimer's Association
- Fulbright U.S. Scholar Program
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Chimal-Juárez, E., Jury-Garfe, N., Gomez-Isaza, L., Troncoso, J. C., & Lasagna-Reeves, C. A. (2026). Spatially resolved transcriptomic profiling identifies distinct signatures in parenchymal and vascular microenvironments in Alzheimer's Disease with Cerebral Amyloid Angiopathy. Alzheimer's & Dementia, 22(2). https://doi.org/10.1002/alz.71208
Vancouver
Chimal-Juárez E, Jury-Garfe N, Gomez-Isaza L, Troncoso JC, Lasagna-Reeves CA. Spatially resolved transcriptomic profiling identifies distinct signatures in parenchymal and vascular microenvironments in Alzheimer's Disease with Cerebral Amyloid Angiopathy. Alzheimer's & Dementia. 2026;22(2). doi:10.1002/alz.71208
BibTeX
@article{ChimalJurez2026,
author = {Chimal-Juárez, Enrique and Jury-Garfe, Nur and Gomez-Isaza, Laura and Troncoso, Juan C and Lasagna-Reeves, Cristian A},
title = {Spatially resolved transcriptomic profiling identifies distinct signatures in parenchymal and vascular microenvironments in Alzheimer's Disease with Cerebral Amyloid Angiopathy},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {2},
doi = {10.1002/alz.71208}
}
EUVIMED